Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac

scientific article

Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/CLPT.1985.163
P698PubMed publication ID4017423
P5875ResearchGate publication ID19145366

P2093author name stringT Hunter
D S Sitar
J A Owen
P A Mitenko
B MacDougall
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpharmacodynamicsQ725307
pharmacokineticsQ323936
P304page(s)228-234
P577publication date1985-08-01
P1433published inClinical Pharmacology & TherapeuticsQ1101529
P1476titleEffects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac
P478volume38

Reverse relations

cites work (P2860)
Q36928338AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway
Q48539811Adventures in drug disposition: pas seulement pâté de foie
Q34741049Clinical pharmacokinetics of sulindac. A dynamic old drug
Q74379228Effect of nabumetone on hemostasis during arthroscopic knee surgery
Q68506534Nonsteroidal anti-inflammatory drugs
Q39560493Novel non-steroidal anti-inflammatory drugs
Q36924607Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study
Q33901684Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes
Q36972832The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1
Q39761044The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly
Q41526041Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?